RS Investment Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q2
$513K Hold
62,980
0.01% 340
2016
Q1
$512K Hold
62,980
0.01% 338
2015
Q4
$760K Buy
+62,980
New +$760K 0.01% 300